Preferred Label : Cangrelor Tetrasodium;

NCIt definition : The tetrasodium salt form of cangrelor, an inhibitor of the platelet adenosine diphosphate (ADP) P2Y12 receptor (P2Y12R), with antiplatelet activity. Upon administration, cangrelor selectively and reversibly binds to P2Y12R, and blocks the platelet signaling pathway. This inhibits the activation of the glycoprotein complex GPIIb/IIIa, fibrinogen binding to platelets and platelet adhesion and aggregation.;

UNII : 2144G00Y7W;

InChIKey : COWWROCHWNGJHQ-OPKBHZIBSA-J;

CAS number : 163706-36-3;

Drug name : Kengreal;

Chemical formula : C17H21Cl2F3N5O12P3S2.4Na;

Détails


Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :


http://www.has-sante.fr/portail/jcms/c_2620141/fr/kengrexal
2016
false
false
false
France
French
treatment outcome
cangrelor
cangrelor
drug therapy, combination
adult
coronary artery disease
percutaneous coronary intervention
injections, intravenous
infusions, intravenous
purinergic P2Y receptor antagonists
platelet aggregation inhibitors
myocardial infarction
embolism and thrombosis
aspirin
hemorrhage
cangrelor
purinergic P2Y receptor antagonists
platelet aggregation inhibitors
receptors, purinergic P2Y12
evaluation of the transparency committee
Cangrelor Tetrasodium
Cangrelor Tetrasodium
angioplasty
emergency treatment
adenosine monophosphate

---
Nous contacter.
30/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.